Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1ALEMTUZUMAB[1] Alemtuzumab[1] D02802 (Name: Alemtuzumab)[1] CD52 💬-[17] 13, 15, 19, 20, 36, 43, 44, 46, 51, 60, 63, 65, 85, 96, 164, 283, 284
2Alemtuzumab (already received by alemtuzumab cohort between 1991 and 1994[1] Alemtuzumab[1] D02802 (Name: Alemtuzumab)[1] CD52 💬-[1] 46
3Alemtuzumab (already received by alemtuzumab cohort between 1991 and 1994)[1] Alemtuzumab[1] D02802 (Name: Alemtuzumab)[1] CD52 💬-[1] 46
4Alemtuzumab (Campath )[1] Alemtuzumab[1] D02802 (Name: Alemtuzumab)[1] CD52 💬-[1] 60
5Alemtuzumab (Campath)[1] Alemtuzumab[1] D02802 (Name: Alemtuzumab)[1] CD52 💬-[1] 15
6Alemtuzumab (GZ402673)[1] Alemtuzumab[1] D02802 (Name: Alemtuzumab)[1] CD52 💬-[1] 13
7Alemtuzumab 0.2 mg[1] Alemtuzumab[1] D02802 (Name: Alemtuzumab)[1] CD52 💬-[2] 65, 164
8Alemtuzumab 0.3 mg[1] Alemtuzumab[1] D02802 (Name: Alemtuzumab)[1] CD52 💬-[2] 65, 164
9Alemtuzumab 12 mg[1] Alemtuzumab[1] D02802 (Name: Alemtuzumab)[1] CD52 💬-[1] 13
10Alemtuzumab 24 mg[1] Alemtuzumab[1] D02802 (Name: Alemtuzumab)[1] CD52 💬-[1] 13
11Alemtuzumab and Rituximab[2] Alemtuzumab,
Rituximab		[2] D02802 (Name: Alemtuzumab),
D02994 		[2] CD52,
MS4A1 💬		[2] , Hematopoietic cell lineage 💬[1] 60
12Alemtuzumab GZ402673[1] Alemtuzumab[1] D02802 (Name: Alemtuzumab)[1] CD52 💬-[1] 13
13Alemtuzumab immunotherapy[1] Alemtuzumab[1] D02802 (Name: Alemtuzumab)[1] CD52 💬-[1] 13
14Alemtuzumab Injection[1] Alemtuzumab[1] D02802 (Name: Alemtuzumab)[1] CD52 💬-[1] 13
15Alemtuzumab Injection [Lemtrada][1] Alemtuzumab[1] D02802 (Name: Alemtuzumab)[1] CD52 💬-[1] 13
16Alemtuzumab, Rituximab[2] Alemtuzumab,
Rituximab		[2] D02802 (Name: Alemtuzumab),
D02994 		[2] CD52,
MS4A1 💬		[2] , Hematopoietic cell lineage 💬[1] 63
17CAMPATH-1H (Alemtuzumab)[1] Alemtuzumab[1] D02802 (Name: Alemtuzumab)[1] CD52 💬-[1] 60
18Filgrastim, Alemtuzumab[2] Alemtuzumab,
Filgrastim		[2] D02802 (Name: Alemtuzumab),
D03235 		[2] CD52,
CSF3R 💬		-[1] 65
19Transplant Conditioning with Mobilization and Alemtuzumab[1] Alemtuzumab[1] D02802 (Name: Alemtuzumab)[1] CD52 💬-[1] 65
20Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan[4] Alemtuzumab,
Fludarabine,
Melphalan,
Thiotepa		[5] D00369 ,
D00583 ,
D01907 ,
D02802 (Name: Alemtuzumab),
D07966 		[2] CD52,
RRM1 💬		-[2] 65, 164